JBLU - Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance.
The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.
Despegar.com shares gained 16.4% to $9.90 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Shattuck Labs, Inc. (NASDAQ: STTK) jumped 127.5% to $4.80 after the company announced initial topline dose-expansion data from its ongoing Phase 1A/B clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients.
- ReShape Lifesciences Inc. (NASDAQ: RSLS) shares gained 63.8% to $0.4110 after the company announced it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.
- C4 Therapeutics, Inc. (NASDAQ: CCCC) shares jumped 59% to $3.7199 after the company announced data from the CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Following the update, Stifel analyst Bradley Canino upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12.
- RiskOn International, Inc. (NASDAQ: ROI) shares gained 38.3% to $0.2016 after declining 9% on Tuesday.
- Innovative International Acquisition Corp. (NASDAQ: IOAC) shares rose 36% to $11.66.
- NextPlay Technologies, Inc. (NASDAQ: NXTP) shares gained 26% to $1.1708 after surging 29% on Tuesday.
- Nephros, Inc. (NASDAQ: NEPH) rose 23% to $3.16.
- SciSparc Ltd. (NASDAQ: SPRC) gained 21.7% to $5.95 after the company announced results for MitoCareX Bio with its drug discovery platform.
- Eos Energy Enterprises, ...